List of Contents

Mixed Reality in Healthcare Market Size, Share, and Trends 2024 to 2034

The global mixed reality in the healthcare market size was USD 3 billion in 2023, estimated at USD 3.28 billion in 2024 and is anticipated to reach around USD 7.86 billion by 2034, expanding at a CAGR of 9% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 1154
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Mixed Reality in Healthcare Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Mixed Reality in Healthcare Market

5.1. Covid-19: Mixed Reality in Healthcare Industry Impact
5.2. Mixed Reality in Healthcare Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Mixed Reality in Healthcare Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Mixed Reality in Healthcare Market Players to deal with Covid-19 Pandemic Scenario

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Adoption of Mixed Reality in Various Healthcare Tools
6.1.1.2. Rising Demand for Digital Solutions in Health Sector
6.1.2. Market Restraints
6.1.2.1. High Cost of Mixed Reality Implementation
6.1.3. Market Opportunities
6.1.3.1. Increasing Investments for Mixed Reality in Healthcare

Chapter 7. Global Mixed Reality in Healthcare Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Mixed Reality in Healthcare Market Revenue by Market Players
7.1.1.2. Mixed Reality in Healthcare Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Component Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Mixed Reality in Healthcare Market, By Component

8.1. Mixed Reality in Healthcare Market, by Component, 2024-2034
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Content & Application
8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Mixed Reality in Healthcare Market, By Application

9.1. Mixed Reality in Healthcare Market, by Application, 2024-2034
9.1.1. Patient Care Management
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Surgery & Surgery Simulation
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Medical Training & Education
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Fitness Management
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Mixed Reality in Healthcare Market, By End-user

10.1. Mixed Reality in Healthcare Market, by End-user, 2024-2034
10.1.1. Surgical Centers & Medical Institutes
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Hospital
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Mixed Reality in Healthcare Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Component (2021-2034)
11.1.2. Market Revenue Forecast by Application (2021-2034)
11.1.3. Market Revenue Forecast by End-user (2021-2034)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2021-2034)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2021-2034)
11.2. Europe
11.2.1. Market Revenue Forecast by Component (2021-2034)
11.2.2. Market Revenue Forecast by Application (2021-2034)
11.2.3. Market Revenue Forecast by End-user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2021-2034)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2021-2034)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Component (2021-2034)
11.3.2. Market Revenue Forecast by Application (2021-2034)
11.3.3. Market Revenue Forecast by End-user (2021-2034)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2021-2034)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2021-2034)
11.4. LATAM
11.4.1. Market Revenue Forecast by Component (2021-2034)
11.4.2. Market Revenue Forecast by Application (2021-2034)
11.4.3. Market Revenue Forecast by End-user (2021-2034)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2021-2034)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2021-2034)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Component (2021-2034)
11.5.2. Market Revenue Forecast by Application (2021-2034)
11.5.3. Market Revenue Forecast by End-user (2021-2034)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2021-2034)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2021-2034)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2021-2034)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2021-2034)

Chapter 12. Company Profiles

12.1. Echopixel, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. Microsoft Corporation
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Firsthand Technology, Inc.
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. Samsung Electronics Co. Ltd.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. Surgical Theater, Inc.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. HTC Corporation
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. Atheer, Inc.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Oculus VR
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Osso VR
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. Proximie
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Precedence Research says the global mixed reality in healthcare market size was valued at USD 3 billion in 2022 and expected to reach USD 7.86 billion by 2034.

The global mixed reality in healthcare market is expected to grow at a CAGR of 9% during the forecast period 2024 to 2034.

Software segment emerged as a market leader with a value share of 58% in 2022 because of rising accessibility and availability of software to the users.

North America being a technology leader on a global scale leads the market for mixed reality in healthcare in 2023 and expected to show its dominance in the upcoming years.

The Asia Pacific expected to witness a lucrative growth during the forthcoming years due to constant improvement in healthcare infrastructure and rising adoption of digital healthcare solutions in the region.

Some of the key players operating in the market are Echopixel, Inc., Microsoft Corporation, Firsthand Technology, Inc., Samsung Electronics Co. Ltd., Surgical Theater, Inc., HTC Corporation, Atheer, Inc., Oculus VR, Osso VR, and Proximie among others.

Mixed reality technology is at its nascent stage and expected to upend the healthcare industry operations in the recent coming years. Presently, the technology is largely helpful to surgeons to execute a medical procedure such as surgery from longer distance. The mixed reality technology enables effective collaboration between digital and physical objects and has gained prominent importance in healthcare applications. In addition to this, the technology is greatly helpful in training and education programs to horn the skills of nurses and primary doctors by providing them virtual specific medical situations that are highly difficult to be arranged in a real clinical setting. For instance, HoloAnatomy introduced a software platform that is greatly helpful for students in the study of human

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us